1 Day EVER -0.41% DJIA 0.59% S&P Mid Cap 400 0.49% Real Estate/Construction 1.61% ...

1 Day MB 19.50% DJIA -0.90% Russell 2K -1.63% Media/Entertainment -0.51% ...

Pheast Therapeutics (“Pheast”), a biotech developing novel macrophage checkpoint therapies to defy cancer, today announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody ...